Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 17683 | 524 | 44.8 | 91% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 222 | 19941 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ADAPHOSTIN | Author keyword | 7 | 67% | 1% | 6 |
| 2 | BONE MARROW MICROVESSEL DENSITY | Author keyword | 2 | 67% | 0% | 2 |
| 3 | PEDIAT PEDIAT ONCOL HEMATOL | Address | 2 | 67% | 0% | 2 |
| 4 | BEATRIX CHILDRENS HOSPUNIV MED GRONINGEN | Address | 2 | 43% | 1% | 3 |
| 5 | STAGE A CHRONIC LYMPHOCYTIC LEUKAEMIA | Author keyword | 1 | 100% | 0% | 2 |
| 6 | AZIENDA OSPED UNIV ARCISPEDALE S ANNA | Address | 1 | 40% | 0% | 2 |
| 7 | ANGIOPOIETIN FAMILY | Author keyword | 1 | 50% | 0% | 1 |
| 8 | ANGX | Author keyword | 1 | 50% | 0% | 1 |
| 9 | ANTI VIRAL STRATEGY | Author keyword | 1 | 50% | 0% | 1 |
| 10 | ASSEMBLAGES MOL MODELISAT IMAGERIE SIMS AMM | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SIMULTANEOUS ELEVATION | 41 | 90% | 3% | 18 |
| 2 | INCREASED ANGIOGENESIS | 22 | 41% | 8% | 41 |
| 3 | BONE MARROW ANGIOGENESIS | 16 | 20% | 13% | 70 |
| 4 | NSC 680410 | 6 | 80% | 1% | 4 |
| 5 | PARACRINE GROWTH | 6 | 80% | 1% | 4 |
| 6 | TYRPHOSTIN AG957 | 6 | 100% | 1% | 4 |
| 7 | MARROW MICROVESSEL DENSITY | 5 | 54% | 1% | 7 |
| 8 | AUTOCRINE VEGF | 2 | 33% | 1% | 4 |
| 9 | HEMANGIOBLASTIC CHARACTERISTICS | 1 | 38% | 1% | 3 |
| 10 | KINASE RECEPTOR INHIBITOR | 1 | 27% | 1% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| The Role of Angiogenesis in Human Non-Hodgkin Lymphomas | 2013 | 11 | 98 | 38% |
| Vascular endothelial growth factor signaling in acute myeloid leukemia | 2013 | 8 | 72 | 43% |
| Contribution of bone microenvironment to leukemogenesis and leukemia progression | 2009 | 88 | 91 | 30% |
| Targeting the vascular endothelial growth factor in hematologic malignancies | 2012 | 4 | 111 | 69% |
| Antiangiogenesis in haematological malignancies | 2008 | 33 | 70 | 39% |
| The role of VEGF in normal and neoplastic hematopoiesis | 2003 | 131 | 87 | 22% |
| Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review) | 2012 | 8 | 113 | 35% |
| Angiogenesis in malignant lymphoma | 2005 | 36 | 45 | 51% |
| Autocrine VEGF loops, signaling pathways, and acute leukemia regulation | 2007 | 15 | 66 | 53% |
| Angiogenesis and antiangiogenic therapy in hematologic malignancies | 2007 | 40 | 127 | 28% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | PEDIAT PEDIAT ONCOL HEMATOL | 2 | 67% | 0.4% | 2 |
| 2 | BEATRIX CHILDRENS HOSPUNIV MED GRONINGEN | 2 | 43% | 0.6% | 3 |
| 3 | AZIENDA OSPED UNIV ARCISPEDALE S ANNA | 1 | 40% | 0.4% | 2 |
| 4 | ASSEMBLAGES MOL MODELISAT IMAGERIE SIMS AMM | 1 | 50% | 0.2% | 1 |
| 5 | BIOL VALROSE IBV | 1 | 50% | 0.2% | 1 |
| 6 | CANC PHARMACOL CLIN PHARMACOL | 1 | 50% | 0.2% | 1 |
| 7 | CLIN BIOINFORMATSHANGHAI CLIN BIOINFORM | 1 | 50% | 0.2% | 1 |
| 8 | DRUG DISCOVERY DEV CANC TREATMENT | 1 | 50% | 0.2% | 1 |
| 9 | GRP IMMUNOGENET | 1 | 50% | 0.2% | 1 |
| 10 | HEMATOL TRANSPLANTS UNIT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000235797 | PLASMA VEGF//MANCHESTER RENAL GRP//PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR |
| 2 | 0.0000203963 | CXXC5//THEOPHYLLAMINE//BIOCHIP ARRAY |
| 3 | 0.0000160658 | MYELOMA BONE DISEASE//CAM DR//HEIM |
| 4 | 0.0000152428 | FLT 1//VEGF RECEPTORS//VEGF165B |
| 5 | 0.0000104959 | MICROVESSEL DENSITY//MICROVESSEL COUNT//CHALKLEY |
| 6 | 0.0000085211 | CLIN SURG UNIT//INTEGRATED SECT TRANSLAT MED ONCOL//DIAGNOST INTERVENT RADIOL UNIT |
| 7 | 0.0000082585 | VEGF POLYMORPHISMS//VEGF POLYMORPHISM//RS2010963 |
| 8 | 0.0000080478 | ANGIOPOIETIN 2//TIE2//ANGIOPOIETIN |
| 9 | 0.0000073584 | METRONOMIC CHEMOTHERAPY//METRONOMIC//LOW DOSE METRONOMIC CHEMOTHERAPY |
| 10 | 0.0000061404 | ENDOSTATIN//ANGIOSTATIN//COLLAGEN XVIII |